中药板块10月24日跌0.56%，振东制药领跌，主力资金净流出5.77亿元

Market Overview - The Chinese medicine sector experienced a decline of 0.56% on October 24, with Zhen Dong Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3950.31, up 0.71%, while the Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - Nonghui Co., Ltd. (603139) with a closing price of 22.86, up 1.87% [1] - Tianmu Pharmaceutical (600671) at 19.28, up 1.80% [1] - Huasen Pharmaceutical (002907) at 17.14, up 1.48% [1] - Major decliners included: - Zhen Dong Pharmaceutical (300158) at 6.93, down 5.33% [2] - Qidi Pharmaceutical (000590) at 12.23, down 3.55% [2] - Zhongsheng Pharmaceutical (002317) at 17.96, down 2.55% [2] Capital Flow - The Chinese medicine sector saw a net outflow of 577 million yuan from institutional investors, while retail investors contributed a net inflow of 462 million yuan [2] - The sector's capital flow indicated a mixed sentiment, with institutional investors withdrawing funds while retail investors increased their positions [2] Individual Stock Capital Flow - Key stocks with significant capital flow included: - China Resources Sanjiu (6660000) with a net inflow of 17.64 million yuan from institutional investors [3] - Jilin Aodong (000623) with a net inflow of 14.57 million yuan [3] - Yunnan Baiyao (000538) with a net inflow of 12.11 million yuan [3] - Conversely, stocks like Huasen Pharmaceutical (002907) experienced a net outflow of 11.31 million yuan from retail investors [3]